Literature DB >> 11150372

Striated muscle cells in non-neoplastic lung tissue: a clinicopathologic study.

F Fraggetta1, M Davenport, G Magro, S Cacciaguerra, R Nash.   

Abstract

This study was performed to study the prevalence, origin, and clinical implication of striated muscle cells in congenital non-neoplastic lung abnormalities. Five cases of striated muscle cell proliferation within congenital non-neoplastic pulmonary abnormalities were identified from a series of 31 (16%) resected specimens obtained at King's College Hospital, London, during the period 1992 to 1998. Lung tissue was also obtained from 48 normal human fetuses and serial sections stained for the presence of striated muscle. A histologic and immunohistochemical study of the clinical cases and the fetal material was performed by using phosphotungstic acid hematoxylin staining and immunostaining for myoglobin and desmin. Striated muscle cells were identified either as a diffuse or a focal proliferation within the lung interstitia of five infants. The congenital lung anomalies were intra-abdominal pulmonary sequestration associated with congenital cystic adenomatoid malformation (CCAM), intrathoracic sequestration again with features of CCAM, an intrathoracic sequestration associated with a congenital diaphragmatic hernia, and 2 Stocker type II intrathoracic CCAMs. Striated muscle cells were not identified in any section of lung tissue derived from the fetal series. Striated muscle cells proliferation in non-neoplastic lung tissue is more common than usually reported. Although the exact origin of such cells is speculative, because it is always detected within pulmonary anomalies, a wide morphogenetic error is likely. The clinical implication of its presence has to be further defined. HUM PATHOL 31:1477-1481. Copyright 2000 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11150372     DOI: 10.1053/hupa.2000.20386

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  2 in total

1.  FGF10 Signaling differences between type I pleuropulmonary blastoma and congenital cystic adenomatoid malformation.

Authors:  Guillaume Lezmi; Virginie Verkarre; Naziha Khen-Dunlop; Shamila Vibhushan; Alice Hadchouel; Caroline Rambaud; Marie-Christine Copin; Jean-Luc Rittie; Alexandra Benachi; Jean-Christophe Fournet; Christophe Delacourt
Journal:  Orphanet J Rare Dis       Date:  2013-09-03       Impact factor: 4.123

2.  Pulmonary choriostoma in a case of tuberous sclerosis complex.

Authors:  S Spalgais; D Gothi; A K Verma
Journal:  J Postgrad Med       Date:  2015 Jul-Sep       Impact factor: 1.476

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.